NOVATEOR logo

Novateor Research Laboratories Ltd

NOVATEOR·BSE·
₹39.00▲ +1.50 (+4.00%)
Market Cap23.60 Cr
PE Ratio229.41
Volume6,000
Day High - Low39.00 - 30.00
52W High-Low39.00 - 20.08

Novateor Research Laboratories Ltd (NOVATEOR): company summary

The company's revenue grew 37.8% annually, but net profit remained at ₹0 crore, with a net profit margin that fell 0.2 percentage points to 2.6%.

Novateor Research Laboratories Ltd (NOVATEOR) is a micro-cap Consumer Goods company valued at ₹24 crore operating in Personal Care on the NSE and BSE.

Recent price move
Novateor Research Laboratories Ltd last traded at ₹39, up 4.00% on the day.
Recent developments
On 2026-03-31, the company reported its latest quarter results, showing revenue of ₹1 crore, flat with the prior year's quarter, but down 31.3% from the same quarter a year earlier. The company's revenue has grown at a 44.9% annual rate over the past three years and 82.3% over the past five years.
Financial performance
The company's revenue grew 37.8% annually, but net profit remained at ₹0 crore, with a net profit margin that fell 0.2 percentage points to 2.6%. The latest quarter saw revenue drop 31.3% year-on-year to ₹1 crore, while net profit stayed at ₹0 crore, though it rose 140.0% from the previous quarter's ₹0 crore.
Valuation multiples
The stock trades at 229.4 times earnings, 1.90 times book value.
Things to watch
The company has not reported any net profit in the latest fiscal year or the latest quarter, despite revenue growth. The net profit margin has declined, and the company's return on equity is very low at 0.9%. The stock is trading at its 52-week high, but the company's net profit remains at zero.
Where it stands
Novateor Research Laboratories Ltd has seen strong revenue growth, but net profit remains at zero. The stock is at its 52-week high, but the company's financials show no profitability. The most significant figure is the company's revenue, which has grown rapidly over the past five years.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
4.5/10
Weak
Fair Value
Sign in to see
ROE
0.88%
Weak
P/E
229.41x
Expensive
Debt / Equity
0.09
Low
Industry
Consumer Goods
Personal Care
Overall View
Mixed

Price performance

Day₹30.00
₹39.00
52W₹20.08
₹39.00
DocStoX take

Supported by growth (8.5) and momentum (7.5), but held back by valuation (0.0). Growth looks strong at 8.5, but that is offset by valuation at 0.0 and quality at 1.7. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
4.5
/10
Weak
Quality
Weak
ROE 0.9%
Valuation
Expensive
P/E 200.0×
Growth
Strong
Revenue +82.3% 5Y CAGR
Risk
Moderate
D/E 0.09
Momentum
Strong
100% of 52-week range

At a glance

Market Cap
₹24 Cr
52W High / Low
₹39 / ₹20
Dividend Yield
0.00%
Promoter Holding
50.75%
EPS (TTM)
₹0.17
Book Value
₹19.01

Key highlights

  • Revenue compounding 82% a year
  • Profit compounding 58% a year
  • Low leverage — D/E 0.09
  • Quality is weak (1.7/10)
  • Valuation is weak (0.0/10)
3 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Consumer Goods stocks · Personal Care

Novateor Research Laboratories Ltd peers in Consumer Goods

Other Consumer Goods stocks on the NSE & BSE. See the full Consumer Goods sector list.